Showing results (1081-1090 of 2,556) with videos related to

Sort By:
Pageof 256
Therapeutics and Clinical Risk Management|July 30, 2019
Use of levosimendan in acute and advanced heart failure: short review on available real-world dataEugene Pashkovetsky, Chhaya Aggarwal Gupta, Wilbert S Aronow
Therapeutics and Clinical Risk Management|May 14, 2008
Drug forecast - the peptide deformylase inhibitors as antibacterial agentsDavid R P Guay
Therapeutics and Clinical Risk Management|May 14, 2008
A randomized study examining the effect of 3 SSRI on premature ejaculation using a validated questionnaireMohamed Arafa, Rany Shamloul
Therapeutics and Clinical Risk Management|May 14, 2008
Treatment of premenstrual dysphoric disorder (PMDD) with a novel formulation of drospirenone and ethinyl estradiolDomenico De Berardis, Nicola Serroni, Rosa Maria Salerno, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
Clinical studies with oral lipid based formulations of poorly soluble compoundsDimitrios G Fatouros, Ditte M Karpf, Flemming S Nielsen, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthmaGennaro D'Amato, Antonello Salzillo, Amedeo Piccolo, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
Using risk management files to identify and address causative factors associated with adverse events in pediatricsPaul D Hain, James W Pichert, Gerald B Hickson, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
Ondansetron oral disintegrating tablets for the prevention of postoperative vomiting in children undergoing strabismus surgeryDeborah S Wagner, Virginia Gauger, Devi Chiravuri, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomasDaniela A Bota, Annick Desjardins, Jennifer A Quinn, et al.
Therapeutics and Clinical Risk Management|May 14, 2008
Naltrexone long-acting formulation in the treatment of alcohol dependenceBankole A Johnson
Pageof 256